» Authors » Nicole C Chang

Nicole C Chang

Explore the profile of Nicole C Chang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 49
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ocampo A, Xue Z, Chang N, Thakkar K, Reddy S, Greenberg S, et al.
Am J Gastroenterol . 2023 Oct; 119(2):262-269. PMID: 37782465
Introduction: Differences in eosinophilic esophagitis (EoE) presentation and outcomes by ethnicity or race remain understudied. We aimed to determine whether EoE patients of Hispanic/Latinx ethnicity or non-White race have differences...
2.
Redd W, Ocampo A, Xue Z, Chang N, Thakkar K, Reddy S, et al.
Ann Allergy Asthma Immunol . 2023 Apr; 131(1):109-115.e2. PMID: 37100277
Background: Patients with eosinophilic esophagitis (EoE) typically have concomitant atopic conditions, but whether there are differences in presentation or treatment response by the number of atopic diseases is unknown. Objective:...
3.
Ketchem C, Ocampo A, Xue Z, Chang N, Thakkar K, Reddy S, et al.
Clin Gastroenterol Hepatol . 2022 Nov; 21(9):2252-2259.e3. PMID: 36410644
Background & Aims: Understanding which eosinophilic esophagitis (EoE) patients will respond to treatment with topical corticosteroids (tCS) remains challenging, and it is unknown whether obesity impacts treatment response. This study...
4.
Xue Z, Miller T, Abramson L, Thakkar K, Ketchem C, Reddy S, et al.
Dis Esophagus . 2022 Jul; 36(1). PMID: 35829628
Eosinophilic esophagitis (EoE) has been associated with autoimmune (AI) and connective tissue disorders (CTDs), but clinical correlates and treatment response to topical corticosteroids (tCS) for patients with both conditions are...
5.
Ketchem C, Thakkar K, Xue A, Reddy S, Abramson L, Greenberg S, et al.
Dig Liver Dis . 2021 Nov; 54(4):477-482. PMID: 34789398
Background: There are few data assessing treatment response in older eosinophilic esophagitis (EoE) patients and we evaluated treatment outcomes to topical corticosteroids (tCS) in this older population. Methods: This retrospective...
6.
Chang N, Thakkar K, Ketchem C, Eluri S, Reed C, Dellon E
Clin Gastroenterol Hepatol . 2021 Oct; 20(8):1701-1708.e2. PMID: 34718172
Background & Aims: There are few data assessing disease progression in eosinophilic esophagitis (EoE) after diagnosis. We aimed to determine outcomes and assess for progression of fibrosis in patients with...
7.
Chang N, Ketchem C, Eluri S, Tappata M, Thakkar K, Corder S, et al.
Dig Dis Sci . 2021 Sep; 67(8):3576-3583. PMID: 34585285
Background: Eosinophilic esophagitis (EoE) is a chronic disease, but the extent of patient loss to follow-up (LTFU) and health care utilization has not been fully investigated. Aim: To determine frequency...
8.
Brenner E, Greenberg S, Chang N, Corder S, Cowherd E, Dellon E
Clin Res Hepatol Gastroenterol . 2021 Jun; 45(5):101746. PMID: 34182183
Background: Gastric and duodenal mucosa may appear normal in eosinophilic gastroenteritis (EGE). Adult gastroenterologists typically biopsy only in the setting of mucosal abnormalities or symptoms, while pediatric providers biopsy all...
9.
Greenberg S, Chang N, Corder S, Reed C, Eluri S, Dellon E
Endoscopy . 2021 Apr; 54(3):243-250. PMID: 33910259
Background: Little is known about esophageal dilation as a long-term treatment approach for eosinophilic esophagitis (EoE). We examined the impact of a "dilate and wait" strategy on symptom management and...